Biblio

Author Title [ Type

] Year

Filters: Author is Lin, Chien-Chin [Clear All Filters]

Journal Article

Lee W-H, Tsai M-T, Tsai C-H, Tien F-M, Lo M-Y, Tseng M-H, Kuo Y-Y, Liu M-C, Yang Y-T, Chen J-C, et al. Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification. Blood Cancer J. 2023;13(1):120.

Wang Y-H, Yao C-Y, Lin C-C, Gurashi K, Amaral FMR, Bossenbroek H, Jerez A, Somervaille TCP, Binder M, Patnaik MM, et al. A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia. Br J Haematol. 2023.

Hou H-A, Liu C-Y, Kuo Y-Y, Chou W-C, Tsai C-H, Lin C-C, Lin L-I, Tseng M-H, Chiang Y-C, Liu M-C, et al. Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia. Oncotarget. 2016.

Gill H, Leung GMK, Ooi MGM, Z Y Teo W, Wong C-L, Choi CWon, Wong G-C, Lao Z, Rojnuckarin P, Castillo MRosario Ir, et al. Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group. Clin Exp Med. 2023.

Yao C-Y, Lin C-C, Wang Y-H, Kao C-J, Tsai XCheng-Hong, Hou H-A, Tien H-F, Hsu C-L, Chou W-C. Kinome expression profiling improves risk stratification and therapeutic targeting in myelodysplastic syndromes. Blood Adv. 2024.

Hung S-Y, Lin C-C, Hsu C-L, Yao C-Y, Wang Y-H, Tsai C-H, Hou H-A, Chou W-C, Tien H-F. The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. Br J Haematol. 2020.

Platzbecker U, Porta MGiovanni D, Santini V, Zeidan AM, Komrokji RS, Shortt J, Valcarcel D, Jonasova A, Dimicoli-Salazar S, Tiong ISoo, et al. Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial. Lancet. 2023.

Wang Y-H, Hou H-A, Lin C-C, Kuo Y-Y, Yao C-Y, Hsu C-L, Tseng M-H, Tsai C-H, Peng Y-L, Kao C-J, et al. A CIBERSORTx-based immune-cell scoring system could independently predict prognosis of myelodysplastic syndrome patients. Blood Adv. 2021.

Wang Y-H, Lin C-C, Yao C-Y, Hsu C-L, Hou H-A, Tsai C-H, Chou W-C, Tien H-F. A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood Adv. 2020;4(4):644-654.